Study [Agroscope_F3] study / subjects / design / samples / assays

Basic properties of your study This page shows the basic information about your study, as well as information on the authorizations.

Publications

  • Metabolic Footprinting of Fermented Milk Consumption in Serum of Healthy Men.
    Pimentel G, Burton KJ, von Ah U, Bütikofer U, Pralong FP, Vionnet N, Portmann R, Vergères G
  • Probiotic yogurt and acidified milk similarly reduce postprandial inflammation and both alter the gut microbiota of healthy, young men.
    Burton KJ, Rosikiewicz M, Pimentel G, Bütikofer U, von Ah U, Voirol MJ, Croxatto A, Aeby S, Drai J, McTernan PG, Greub G, Pralong FP, Vergères G, Vionnet N

Contacts

  • Pimentel, Grégory
    Involved Scientist

Authorization

Public Design
Yes
Readers
Writers
Study title
Function Fermented Food (F3)
Template
Intervention/Observation study
title
Function Fermented Food (F3)
description
Serum metabolome and stool microbiota after daily intake of milk or probiotic yoghurt
code
Agroscope_F3
startDate
2014-03-01 00:00:00.0
Study type
Human Intervention
Principle Investigator
Guy Vergères
Primary endpoint
Metabolic and microbiota footprint of fermented milk consumption.
Objectives
Metabolic and microbiota footprint of fermented milk consumption.
Central conclusion
Probiotic yogurt and acidified milk similarly reduce postprandial inflammation and both alter the gut microbiota. Identification of bionarkers of fermented milk consumption.
Main health-related outcome
Probiotic yogurt and acidified milk similarly reduce postprandial inflammation
Exclusion criteria
Chronic or acute disease, hypertension, regular medication, moderate or intense physical activity (exceeding 6 h/week), nutritional supplements, antibiotic treatment in the 6 months preceding the study and a history of anaemia.
Inclusion criteria
Subjects aged 18–40 years with a stable, healthy BMI (18·5–25·0 kg/m2), regular dietary and physical activity habits, and no evidence of dietary intolerances, restrictions or adverse reactions to dairy products
Institute
Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, 1011 Lausanne, Switzerland. https://www.chuv.ch/fr/edm/edm-home
Collaborators involved
Grégory Pimentel, Kathryn J Burton, Ueli von Ah, Ueli Bütikofer, François P Pralong, Nathalie Vionnet, Reto Portmann, and Guy Vergères
Country (for multicentre study overall PI)
Switzerland
Consortium
not defined
Clinicaltrials.gov or similar number
NCT02230345
Was the study approved by an ethics committee?
Yes
Ethical approval number
392/13, Vaud, Switzerland
Study protocol
Did the individuals providing data sign informed consent?
Yes
Study design
Crossover
Diet short codes and descriptions
Control group
No
Randomisation
Yes
Full randomisation method (if any)
Computer random number generator
Blinding (yes/no)
Yes
Blinding method
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Study terminated?
Yes
Factorial design?
Yes
Number of factors (for factorial designs only)
2
Total number of arms (Give number of distinct treatments in study)
2
Explanatory text (Give a textual account of the overall design leading to the total number of groups) or provide the study protocol.
Cross over design with 2 groups: 2 weeks daily intake of acidified milk or yoghurt; followed by 2 weeks daily intake of yoghurt or acidified milk.
Treatments (Number and types of foods, drugs or other treatments compared)
2: acidified milk or yoghurt
Number of volunteers screened N(M:xx, F: xx)
M:393
Number of volunteers enrolled N(M:xx, F: xx)
M:14
Number of subjects (Male; Female)
M:13
Start of recruitment (Start year or date)
2013-10-01 00:00:00.0
End of recruitment (End year or date)
2014-01-01 00:00:00.0
Follow-up planned
No

back to list